Clinical Trials in Wisconsin

Are you looking to enroll in a clinical trial in Wisconsin? With new trials like "Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver" and "Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma", the Badger State has established itself as a great location for clinical research studies, particularly in cities like Madison and Milwaukee.

While some individuals are looking for paid clinical trials, others want to help advance gastroenterology and psychology clinical research in Wisconsin. To begin your search for Wisconsin clinical trials, use the form on the right.

Use our guide to learn which trials are right for you!


We've found
5,821
clinical trials in
Wisconsin

Oncology Clinical Trial
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Wausau, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Marinette, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Marinette, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Menomonee Falls, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Racine, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Rhinelander, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Two Rivers, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Waukesha, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Wausau, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Wisconsin Rapids, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Appleton, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Manitowoc, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Minocqua, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Mukwonago, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Oconomowoc, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Oshkosh, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Racine, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Rice Lake, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Summit, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Waukesha, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Marinette, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Rhinelander, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Rhinelander, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Weston, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Marinette, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Marshfield, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Rhinelander, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Two Rivers, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Waukesha, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Weston, WI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Chippewa Falls, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Fond Du Lac, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Grafton, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
La Crosse, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Waukesha, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Wausau, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Wisconsin Rapids, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer
Status: Enrolling, Phase II
Updated: 4/5/2016
mi
from
Menomonee Falls, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer
Status: Enrolling, Phase II
Updated: 4/5/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer
Status: Enrolling, Phase II
Updated: 4/5/2016
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer
Status: Enrolling, Phase II
Updated: 4/5/2016
mi
from
West Allis, WI
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Waukesha, WI
Click here to add this to my saved trials
Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Mitigation of Radiation Pneumonitis and Fibrosis
Status: Enrolling, Phase II
Updated: 4/5/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Burlington, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Marshfield, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Minocqua, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Mukwonago, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Oconomowoc, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Oshkosh, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Racine, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Rice Lake, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Summit, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Janesville, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Marinette, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
West Allis, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Weston, WI
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Leukemia Clinical Trial
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 7/24/2014
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Leukemia Clinical Trial
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 7/24/2014
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit
Status: Enrolling, Phase II
Updated: 1/15/2010
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 11/19/2014
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Respiratory Virus Hospitalization Study (FLU 003 Plus)
Status: Enrolling
Updated: 11/30/2015
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
Status: Enrolling
Updated: 3/22/2013
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
Status: Enrolling
Updated: 3/22/2013
mi
from
Wausau, WI
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Status: Enrolling, Phase II
Updated: 9/19/2014
mi
from
Johnson Creek, WI
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Status: Enrolling, Phase II
Updated: 9/19/2014
mi
from
Manitowoc, WI
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Status: Enrolling, Phase II
Updated: 9/19/2014
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Status: Enrolling, Phase II
Updated: 9/19/2014
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Status: Enrolling, Phase II
Updated: 9/19/2014
mi
from
Two Rivers, WI
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Status: Enrolling, Phase II
Updated: 9/19/2014
mi
from
Waukesha, WI
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Status: Enrolling, Phase II
Updated: 9/19/2014
mi
from
Weston, WI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 2/22/2013
mi
from
Green Bay, WI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 2/22/2013
mi
from
Green Bay, WI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 2/22/2013
mi
from
Manitowoc, WI
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology, Other Clinical Trial
Hyperbaric Oxygen Therapy in Chronic Traumatic Brain Injury or Post-Traumatic Stress Disorder
Status: Enrolling
Updated: 4/22/2014
mi
from
Fond du Lac, WI
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/5/2012
mi
from
Green Bay, WI
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/5/2012
mi
from
Janesville, WI
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/5/2012
mi
from
Manitowoc, WI
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 58
View Clinical Trial Facilties in Wisconsin